OABI Insider Trading
Insider Ownership Percentage: 8.60%
Insider Buying (Last 12 Months): $1,356,312.50
Insider Selling (Last 12 Months): $458,129.12
OmniAb Share Price & Price History
Current Price: $1.93
Price Change: ▲ Price Increase of +0.08 (4.32%)
As of 04/11/2025 05:00 PM ET
OmniAb Insider Trading History
OmniAb Institutional Trading History
Data available starting January 2016
OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.
Read More on OmniAb
Volume
851,877 shs
Average Volume
559,772 shs
Market Capitalization
$235.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.06
Who are the company insiders with the largest holdings of OmniAb?
Who are the major institutional investors of OmniAb?
Which major investors are selling OmniAb stock?
Within the previous quarter, OABI stock was sold by these institutional investors:
- Woodstock Corp
Within the last year, company insiders that have sold OmniAb company stock include:
- Matthew W Foehr (CEO)
- John L Higgins (Director)
- Charles S Berkman (Insider)
Learn More investors selling OmniAb stock.